The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
68Ga-PSMA PET/CT response and clinical outcomes in patients treated with enzalutamide as first-line therapy for metastatic castration-resistant prostate cancer (mCRPC): Results of a prospective study.
 
Emilio Francesco Giunta
Travel, Accommodations, Expenses - Bayer; Janssen
 
Paola Caroli
No Relationships to Disclose
 
Emanuela Scarpi
No Relationships to Disclose
 
Amelia Altavilla
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen
Travel, Accommodations, Expenses - Janssen
 
Irene Marini
No Relationships to Disclose
 
Monica Celli
No Relationships to Disclose
 
Chiara Casadei
Travel, Accommodations, Expenses - Pfizer
 
Cristian Lolli
Consulting or Advisory Role - Ipsen; Janssen; MSD
 
Giuseppe Schepisi
Consulting or Advisory Role - Janssen; Pfizer
 
Sara Bleve
No Relationships to Disclose
 
Nicole Brighi
Consulting or Advisory Role - Bristol-Myers Squibb
Travel, Accommodations, Expenses - AAA/Endocyte/Novartis; Ipsen; Janssen; Novartis; Pfizer
 
Maria Concetta Cursano
Travel, Accommodations, Expenses - Ipsen
 
Giovanni Martinelli
Consulting or Advisory Role - Abbvie; Celgene; Daichii Sankyo; Incyte; Jazz Pharmaceuticals; Pfizer; Roche
Speakers' Bureau - Jazz Pharmaceuticals; Menarini; Novartis
Research Funding - Daichii Sankyo; Pfizer
Travel, Accommodations, Expenses - Abbvie; daichii sankyo; Jazz Pharmaceuticals; Jazz Pharmaceuticals; Pfizer
 
Federica Matteucci
No Relationships to Disclose
 
Ugo De Giorgi
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Clovis Oncology; Dompé Farmaceutici; Eisai; Ipsen; Janssen; Merck; MSD; Novartis; Pfizer; PharmaMar
Research Funding - AstraZeneca (Inst); Roche (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - AstraZeneca/Daiichi Sankyo; Ipsen; Merck; Pfizer